Human-steered next-generation machine learning for reviving drug design
Bidragets beskrivning
The aim of this project is to develop machine learning methods that enable reviving drug development, which has currently been significantly slowed down due to a huge increase of development cost. We develop new methods, with which drug design can take into account both the enlarging measurement databases and expertise of the drug developers. The methods will be general-purpose, and will be taken into use widely in other fields as well, in the Finnish Center for Artificial Intelligence FCAI where the research will be carried out.
Visa merStartår
2021
Slutår
2025
Beviljade finansiering
Rollen i Finlands Akademis konsortium
Partner
Övriga parter i konsortiet
Övriga uppgifter
Finansieringsbeslutets nummer
342077
Vetenskapsområden
Data- och informationsvetenskap
Forskningsområden
Laskennallinen data-analyysi
Identifierade teman
bioinformatics